Dr. Traynor is one of eight recipients who were awarded more than $1.8 million in funding from the Michigan Translational Research and Commercialization Life Sciences Innovation Hub, and the Office of the Vice President for Research and Innovation Partnerships for their innovative biomedical research projects. Dr. Traynor's project is designed to address opioid use disorder.
Led by researchers at the University of Michigan, Corewell Health and Wayne State University, the eight projects aim to address significant unmet health-care needs and enhance quality of life.
The MTRAC Life Sciences Innovation Hub is supported by the Michigan Economic Development Corporation and is co-managed by Innovation Partnerships, based in OVPR, and Fast Forward Medical Innovation, based in the Medical School Office of Research.
Since 2014, the hub has provided more than $20 million to support projects led by Michigan-based researchers that range in scope from medical devices and therapeutics to diagnostics and health information technology. Supported projects have yielded more than $180 million in follow-on funding, launched more than 40 startups and created 140 high-tech jobs in Michigan.
“The MTRAC Life Sciences Hub has a proven track record of generating strong positive impact across our state and region,” said Kelly Sexton, associate vice president for research – innovation partnerships and economic impact. “We are incredibly grateful for the continued investment in high-tech biomedical research from the MEDC and the U-M Office of the Vice President for Research.”
Congratulations to Dr. Traynor and the Domino Center.